AVTE - Aerovate Therapeutics reports Q1 GAAP EPS of -$0.83 May, 14 2024 12:34 PM Aerovate Therapeutics Inc. 2024-05-14 12:34:24 ET More on Aerovate Therapeutics Seeking Alpha’s Quant Rating on Aerovate Therapeutics Historical earnings data for Aerovate Therapeutics Financial information for Aerovate Therapeutics For further details see: Aerovate Therapeutics reports Q1 GAAP EPS of -$0.83